{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (2Q26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.10 vs. cons $1.04",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (2Q26)",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.295B vs. cons $5.26B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted EBIT margin (2Q26)",
      "prediction": "BEAT",
      "answer": "pred ~14.8% vs. cons 14.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.90 midpoint vs. cons $4.89 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted EBIT margin guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~15.55% midpoint vs. cons 15.50% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% midpoint vs. cons 3.5% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.3,
  "day5_path": "FADE",
  "day5_rationale": "Day-5 residual ~+0.3% vs. day-1 ~+1.5%: the operating-quality beat should initially help, but reaffirmed FY2026 guidance near the ~$4.90 midpoint versus ~$4.89 consensus leaves little estimate-revision upside, while demanding second-half margin assumptions and the CFO transition limit follow-through.",
  "day5_confidence": "MEDIUM"
}